Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
Biotech
Sanofi inks $470M Vigil buyout to snag Alzheimer's prospect
With the biotech into the last year of its cash runway, Sanofi has swept in to secure a small molecule that could challenge Novartis' antibody.
Nick Paul Taylor
May 22, 2025 4:49am
Regeneron’s $256M bid wins 23andMe bankruptcy auction
May 19, 2025 10:37am
BioMarin inks $270M Inozyme buyout, bagging phase 3 prospect
May 16, 2025 8:46am
Activist investor fails to derail Alumis' Acelyrin merger
May 14, 2025 7:45am
Masimo reports cyberattack slowing manufacturing, sales
May 6, 2025 5:00pm
HistoSonics considering a sale to major medtechs: report
May 2, 2025 11:30am
